Filing Details
- Accession Number:
- 0001179110-22-000399
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-11 16:19:22
- Reporting Period:
- 2022-01-07
- Accepted Time:
- 2022-01-11 16:19:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578852 | Elliott Mark Boulding | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Exec. Vp And Clo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-01-07 | 885 | $38.53 | 47,489 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-01-07 | 14,400 | $0.00 | 61,889 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-01-07 | 54,000 | $0.00 | 54,000 | $38.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
54,000 | 2032-01-06 | No | 4 | A | Direct |
Footnotes
- Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs.
- Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
- This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.